Scientific publications

Scientific articles authored by Novo Nordisk

The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.

4938 results found.
Showing results 121-140
Journal Author Year
Diabetologia

High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non- diabetic family members of type 2 diabetic patients

Gjesing AP ; Hornbak M ; Allin KH ; Ekstrom CT ; Urhammer SA ; Eiberg H ; Pedersen O ; Hansen T 2014
Drug Discovery Today

Dynamic epigenetic responses to muscle contraction

Rasmussen M ; Zierath JR ; Barres R 2014
Drugs and Aging

Ultra-Long Pharmacokinetic Properties of Insulin Degludec are Comparable in Elderly Subjects and Younger Adults with Type 1 Diabetes Mellitus

Korsatko S ; Deller S ; Mader JK ; Glettler K ; Koehler G ; Treiber G ; Urschitz M ; Wolf M ; Hastrup H ; Sondergaard F ; Haahr H ; Pieber TR 2014
Ecology and Society

Development and Use of a Bioeconomic Model for Management of Mussel Fisheries under Different Nutrient Regimes in the Temperate Estuary of the Limfjord, Denmark - art. no. 14

Timmermann K ; Dinesen GE ; Markager S ; Ravn-Jonsen L ; Bassompierre M ; Roth E ; Stottrup JG 2014
EMBO Reports

Stable MCC binding to the APC/C is required for a functional spindle assembly checkpoint

Hein JB ; Nilsson J 2014
EMBO Reports

A direct role of Mad1 in the spindle assembly checkpoint beyond Mad2 kinetochore recruitment

Kruse T ; Larsen MSY ; Sedgwick GG ; Sigurdsson JO ; Streicher W ; Olsen JV ; Nilsson J 2014
Endocrine Practice

REDUCED RISK OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES REQUIRING HIGH DOSES OF BASAL INSULIN: A META-ANALYSIS OF 5 RANDOMIZED BEGIN TRIALS

Rodbard HW ; Gough S ; Lane W ; Korsholm L ; Bretler DM ; Handelsman Y 2014
Epidemiology and Infection

The use of combined heart rate response and accelerometry to assess the level and predictors of physical activity in tuberculosis patients in Tanzania

Faurholt-Jepsen M ; Faurholt-Jepsen D ; Range N ; Praygod G ; Jeremiah K ; Aabye MG ; Changalucha J ; Krarup H ; Christensen DL ; Andersen AB ; Brage S ; Friis H 2014
European Journal of Human Genetics

The Genome of the Netherlands: design, and project goals

Boomsma DI ; Wijmenga C ; Slagboom EP ; Swertz MA ; Karssen LC ; Abdellaoui A ; Ye K ; Guryev V ; Vermaat M ; van Dijk F ; Francioli LC ; Hottenga JJ ; Laros JFJ ; Li QB ; Li YR 2014
European Journal of Human Genetics

Variation and association to diabetes in 2000 full mtDNA sequences mined from an exome study in a Danish population

Li ST ; Besenbacher S ; Li YR ; Kristiansen K ; Grarup N ; Albrechtsen A ; Sparso T ; Korneliussen T ; Hansen T ; Wang J ; Nielsen R ; Pedersen O ; Bolund L ; Schierup MH 2014
European Journal of Human Genetics

Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMD/BMD: a multi- population diagnostic study

Wei XM ; Dai Y ; Yu P ; Qu N ; Lan ZZ ; Hong XF ; Sun Y ; Yang GH ; Xie SQ ; Shi Q ; Zhou HL ; Zhu Q ; Chu YX ; Yao FX ; Wang JM 2014
European Journal of Pharmaceutical Sciences

Insulin aspart pharmacokinetics: An assessment of its variability and underlying mechanisms

Rasmussen CH ; Roge RM ; Ma ZL ; Thomsen M ; Thorisdottir RL ; Chen JW ; Mosekilde E ; Colding-Jorgensen M 2014
European Journal of Pharmaceutical Sciences

Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration

Agerso H ; Overgaard RV ; Petersen MB ; Hansen L ; Hermit MB ; Sorensen MH ; Petersen LC ; Hilden I 2014
European Journal of Pharmaceutics and Biopharmaceutics

The role of citric acid in oral peptide and protein formulations: Relationship between calcium chelation and proteolysis inhibition

Welling SH ; Hubalek F ; Jacobsen J ; Brayden DJ ; Rahbek UL ; Buckley ST 2014
European Journal of Preventive Cardiology

A prediction of the renal and cardiovascular efficacy of aliskiren in ALTITUDE using short-term changes in multiple risk markers

Smink PA ; Hoekman J ; Grobbee DE ; Eijkemans MJC ; Parving HH ; Persson F ; Ibsen H ; Lindholm L ; Wachtell K ; de Zeeuw D ; Heerspink HJL 2014
Experimental Dermatology

Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin

Bech R ; Otkjaer K ; Birkelund S ; Vorup-Jensen T ; Agger R ; Johansen C ; Iversen L ; Kragballe K ; Romer J 2014
Expert Opinion on Drug Delivery

Advances in targeted delivery of small interfering RNA using simple bioconjugates

Nielsen C ; Kjems J ; Sorensen KR ; Engelholm LH ; Behrendt N 2014
Expert Opinion on Drug Delivery

Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals

Pfutzner A ; Forst T ; Niemeyer M ; Bailey T 2014
Expert Opinion on Drug Delivery

Orally active-targeted drug delivery systems for proteins and peptides

Li XY ; Yu MR ; Fan WW ; Gan Y ; Hovgaard L ; Yang MS 2014
Expert Review of Medical Devices

Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay

Meinhardt U ; Eiholzer U ; Seitz L ; Bogelund M ; Kappelgaard AM 2014